Energy restriction and exercise modulate angiopoietins and vascular endothelial growth factor expression in the cavernous tissue of high-fat diet-fed rats

Asian Journal of Andrology

Volumn 14, Issue 4, 2012, Pages 635-642

  Tomada, Ins ^a,b   Tomada, Nuno ^b,c   Almeida, Henrique ^a,b   Neves, Delminda ^a,b  

^a University of Porto   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

angiopoietins; corpus cavernosum; endothelial dysfunction; energy restriction; exercise; high fat diet; VEGF

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FAT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN KINASE B; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ARTICLE; CALORIC RESTRICTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORPUS CAVERNOSUM; EXERCISE; IMMUNOFLUORESCENCE TEST; LIPID DIET; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; BLOOD PRESSURE; CHOLESTEROL, HDL; DIET, HIGH-FAT; DIETARY FATS; ENERGY INTAKE; MALE; MICROTUBULE PROTEINS; NITRIC OXIDE SYNTHASE TYPE III; PENIS; PHYSICAL CONDITIONING, ANIMAL; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84863672272     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2011.131     Document Type: Article

References (53)

1. Braun M, Wassmar G, Klotz T, Reifenrath B, MathersMet al. Epidemiology of erectile dysfunction: Results of the Cologne Male-Survey. Int J Impot Res 2000; 12: 305-11.
2. Brunner H, Cockcroft J, Deanfield J, Donald A, Ferrannini E et al. Endothelial function and dysfunction. Part II: ASSOCIATION with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23: 233-46.
3. Esposito K, Giugliano D. Obesity, the metabolic syndrome, and sexual dysfunction. Int J Impot Res 2005; 17: 391-8.
4. Boneti P, Lerman L, Lerman A. Endothelial dysfunction: A marker of atherosclerotic risk. Atheroscler Thromb Vasc Biol 2003; 23: 168-75.
5. Saenz de Tejada I, Angulo J, Cellek S, Gonzá lez-Cadavid N, Heaton J et al. Physiology of erectile dysfunction. J Sex Med 2004; 1: 254-65.
6. Guay AT. ED2: ERECTILE dysfunction5endothelial dysfunction. Endocrinol Metab Clin N Am2007; 36: 453-63.
7. Naderali E, Williams G. Prolonged endothelial-dependent and -independent arterial dysfunction induced in the rat by short-term feeding with a high-fat, high-sucrose diet. Atherosclerosis 2003; 166: 253-9.
8. Esposito K, Ciotola M, Sasso F, Cozzolino D, Saccomanno F et al. Effect of a single high-fat meal on endothelial function in patients with the metabolic syndrome: Role of tumor necrosis factor-alpha. Nutr Metab Cardiovasc Dis 2007; 17: 274-9.
9. Musicki B, Liu T, Strong T, Jin L, LaughlinMHet al. Low-fat diet and exercise preserve eNOS regulation and endothelial function in the penis of early atherosclerotic pigs: A molecular analysis. J Sex Med 2008; 5: 552-61.
10. Hürlimann D, Ruschitazka F, Lüscher TF.The relationship between the endothelium and the vessel wall. Eur Heart J Suppl 2002; 4 (Suppl A): a1-7.
11. Musicki B, Liu T, Lagoda GA, Strong TD, Sezen SF et al. Hypercholesterolemiainduced erectile dysfunction: Endothelial nitric oxide synthase (eNOS) uncoupling in the mouse penis by NAD(P)H oxidase. J Sex Med 2010; 7: 3023-32.
12. Ferrara N. Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev 2005; 25: 581-611.
13. Ferrara N. Role of vascular endothelial growth factoring regulation of physiological angiogenesis. Am J Physiol Cell Physiol 2001; 280: 1358-66.
14. Eklund L, Olsen B. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodelling. Exp Cell Res 2006; 312: 630-41.
15. Morisada T, Kubota Y, Urano T, Suda T, Oike Y. Angiopoietins and angiopoietin-like proteins in angiogenesis. Endothelium 2006; 13: 71-9.
16. Maisonpierre P, Suri C, Jones P, Bartunkova S, Wiegand SJ et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55-60.
17. Watts G, Chew K, Stuckey B. The erectile-endothelial dysfunction nexus: New opportunities for cardiovascular risk prevention. Nat Clin Pract Cardiovasc Med 2007; 4: 263-73.
18. Kaya C, Uslu Z, Karaman I. Is endothelial function impaired in erectile dysfunction patients? Int J Impot Res 2006; 18: 55-60.
19. Yavuzgil O, Altay B, Zoghi M, Gürgün C, Kayikçiog? lu M et al. Endothelial function in patients with vasculogenic erectile dysfunction. Int J Cardiol 2005; 103: 19-26.
20. Naderali E, Brown M, Pickavance C, Wilding J, Doyle P et al. Dietary obesity in the rat induces endothelial dysfunction without causing insulin resistance: A possible role for triacylglycerols. Clin Sci 2001; 101: 499-506.
21. Naderali E, Pickavance C, Wilding J, Williams G. Diet-induced endothelial dysfunction in the rat is independent of the degree of increase in total body weight. Clin Sci 2001; 100: 635-41.
22. Naderali E, Fatani S, Williams G. Chronic withdrawal of a high-palatable obesityinducing diet completely reverses metabolic and vascular abnormalities associated with dietary-obesity in the rat. Atherosclerosis 2004; 172: 63-9.
23. Mundy A, Haas E, Bhattacharya I, Widmer CC, Kretz M et al. Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: Implications for diet-induced obesity. Cardiovasc Res 2007; 73: 368-75.
24. Esposito K, Guigliano F, Di Palo C, Giugliano G, Marfella R et al. Effect of lifestyle changes on erectile dysfunction in obese men: A randomized controlled trial. JAMA 2004; 291: 2978-84.
25. Belardinelli R, Lacalaprice F, Faccenda E, Purcaro A, Perca G. Effect of short-term moderate exercise training on sexual function in male patients with chronic stable heart failure. Int J Cardiol 2005; 101: 83-90.
26. Kratzik CW, Lackner JE, Märk I, Rücklinger E, Schmidbauer J et al. How much physical activity is needed to maintain erectile function? Results of the Androx Vienna Municipality Study. Eur Urol 2009; 55: 509-17.
27. Faraone-Mennella MR, Marini M, Ferone A, Cacace O, Liguoro A et al. Physical exercise activates the poly(ADP-ribosyl)ation system in rat testes. Biol Regul Homeost Agents 2010; 24: 325-33.
28. Moore M, Murgatroyd P, Goldberg G, Jebb S. Restoration of energy balance following a diet- or exercise-induced energy deficit.. Proc Nutr Soc 2000; 59: 124.
29. Estadella D, Oyama L, Da'maso A, Ribeiro E, Oller do Nascimento C. Effect of palatable hyperlipidic diet on lipid metabolism of sedentary and exercised rats. Nutrition 2004; 20: 218-24.
30. Cruciani-Guglielmacci C, Vincent-Lamon M, Rouch C, Orosco M, Ktorza A et al. Early changes in insulin secretion and action induced by high fat diet are related to a decreased sympathetic tone. Am J Physiol Endocrinol Metab 2005; 288: 48-54.
31. Feig JE, Shamir R, Fisher EA. Atheroprotective effects of HDL: Beyond reverse cholesterol transport. Curr Drug Targets 2008; 9: 196-203.
32. Bal K, Oder M, Sahin A, KarataşCT, Demir O et al. Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: Metabolic backgrounds of erectile dysfunction. Urology 2007; 69: 356-60.
33. Haram PM, Kemi OJ, Lee SJ, Bendheim Mø, Al-Share QY et al. Aerobic interval training vs. continuous moderate exercise in the metabolic syndrome of rats artificially selected for low aerobic capacity. Cardiovasc Res 2009; 81: 723-32.
34. Schulze M, Hu F. Dietary approaches to prevent the metabolic syndrome. Quality versus quantity of carbohydrates. Diabetes Care 2004; 27: 613-4.
35. Hannan J, Heaton J, Adams M. Recovery of erectile function in aging hypertensive and normotensive rats using exercise and caloric restriction. J Sex Med 2007; 4: 886-97.
36. Tomada I, Tomada N, Almeida H, Vendeira P, Neves D. Morphometric and molecular study of corpus cavernosum of the rat after long-term high-fat diet intake. Microsc Microanal 2009; 15 (Suppl 3): 21-2.
37. Wever RM, Lücher TF, Consentino F, Rabelink TJ. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 1998; 97: 108-12.
38. Nisoli E, Tonello C, Cardile A, Cozzi V, Bracale R et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005; 310: 314-7.
39. Kuru O, SentürkÜK, Koçer G, Ozdem S, Başkurt OK et al. Effect of exercise training on resistance arteries in rats with chronic NOS inhibition. J Appl Physiol 2009; 107: 896-902.
40. Rogers R, Graziottin T, Lin C, Kan Y, Lue T. Intracavernosal vascular endothelia growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res 2003; 15: 26-37.
41. Jin HR, Kim WJ, Song JS, Piao S, Tumurbaatar M et al. Intracavernous delivery of synthetic Angiopoietin-1 protein as a novel therapeutic strategy for erectile dysfunction in the type II diabetic db/db mouse. J Sex Med 2010; 7: 3635-46.
42. Liu X, Lin C, Graziottin T, Resplande J, Lue T. Vascular endothelial growth factor promotes proliferation and migration of cavernous smooth muscle cells. J Urol 2001; 166: 354-60.
43. Jesmin S, Sakuma I, Salah-Eldin A, Nonomura K, Hattori Y et al. Diminished penile expression of vascular endothelial growth factor and its receptors at the insulinresistant stage of a type II diabetic rat model: A possible cause for erectile dysfunction in diabetes. J Mol Endocrinol 2003; 31: 401-18.
44. Neves D, Santos J, Tomada N, Almeida H, Vendeira P. Aging and orchidectomy modulate expression of VEGF receptors (Flt-1 and Flk-1) on corpus cavernosum of the rat. Ann NY Acad Sci 2006; 1067: 164-72.
45. Tomada N, Tomada I, Vendeira P, Neves D. Expression of vascular endothelial growth factor and angiopoietins in human corpus cavernosum. BJU Int 2010; 105: 269-73.
46. Tomada N, Tomada I, Cruz F, Vendeira P, Neves D. Characterization of VEGF and angiopoietins in human corpus cavernosum during aging. J Sex Med 2010; 7: 1410-8.
47. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 2006; 39: 469-78.
48. Fiedler U, Scharpfenecker M, Koidl S, Hegen A, Grunow V et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004; 103: 4150-6.
49. Nykänen A, Krebs R, Saaristo A, Turunen P, Alitalo K et al. Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis. Circulation 2003; 107: 1308-14.
50. DeBusk LM, Hallahan DE, Lin PC. Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway. Exp Cell Res 2004; 298: 167-77.
51. Hurt KJ, Musicki B, Palese MA, Crone JK, Becker RE et al. Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection. Proc Natl Acad Sci USA 2002; 99: 4061-6.
52. Li WJ, Zhou J, Li BJ, Wang H, Peng YB et al. PARP inhibition restores erectile function by suppressing corporal smooth muscle apoptosis in diabetic rats. J Sex Med 2011; 8: 1072-82.
53. Ryu JK, Shin HY, Song SU, Oh SM, Piao S et al. Downregulation of angiogenic factors and their downstream target molecules affects the deterioration of erectile function in a rat model of hypercholesterolemia. Urology 2006; 67: 1329-34.